We understand the biochemistry, know the therapeutic applications, and provide the medical supervision that makes high-dose therapy both safe and effective
Reference Schapira, AHV 2006, Mitochondrial Disease, The Lancet , vol
This phase will evaluate retatrutides safety and efficacy in treating obesity and its complications comprehensively
Semaglutide binds more effectively to GLP-1 receptors, producing stronger appetite suppression
This new molecule, by acting synergistically on combined systems known to be altered in T2DM [33, 34], could indeed expand the therapeutic potential of GLP-1 agonists/analogues, suggesting new scenarios in terms of improving glycemic control, weight management, and hopefully providing protection against chronic micro-macrovascular complications and not only limited to hepatic complications